Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials

Research output: Contribution to journal › Article › Academic › peer-review

71 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{8162830fa5224985b772ac4ba5b11713,

title = "Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials",

author = "L Collette and T Burzykowski and Fritz Schr{\"o}der",

year = "2006",

doi = "10.1016/j.ejca.2006.02.011",

language = "Undefined/Unknown",

volume = "42",

pages = "1344--1350",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "10",

}

TY - JOUR

T1 - Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials

AU - Collette, L

AU - Burzykowski, T

AU - Schröder, Fritz

PY - 2006

Y1 - 2006

U2 - 10.1016/j.ejca.2006.02.011

DO - 10.1016/j.ejca.2006.02.011

M3 - Article

C2 - 16730974

SN - 0959-8049

VL - 42

SP - 1344

EP - 1350

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 10

ER -